Advertisement

Ads Placeholder
Loading...

Dechra Pharmaceuticals PLC

DCHPF•PNK
Healthcare
Medical - Pharmaceuticals
$46.90
$-0.10(-0.21%)
U.S. Market opens in 50h 44m

Dechra Pharmaceuticals PLC (DCHPF) Stock Overview

Explore Dechra Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.3B
P/E Ratio-144.59
EPS (TTM)$-0.31
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

DCHPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dechra Pharmaceuticals PLC (DCHPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -144.59 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-0.89%
6-Month Change
3.65%
Year-to-Date (YTD) Change
45.44%
1-Year Change
39.79%
3-Year Change
3.08%
5-Year Change
19.80%
All-Time (Max) Change
196.84%

Contact Information

https://www.dechra.com
44 1606 814730
24 Cheshire Avenue, Northwich, NaN, CW9 7UA

Company Facts

24,570 Employees
IPO DateJul 11, 2016
CountryGB

Frequently Asked Questions